Human Ebola virus infection results in substantial immune activation

Abstract

Four Ebola patients received care at Emory University Hospital, presenting a unique opportunity to examine the cellular immune responses during acute Ebola virus infection. We found striking activation of both B and T cells in all four patients. Plasmablast frequencies were 10-50% of B cells, compared with less than 1% in healthy individuals. Many of these proliferating plasmablasts were IgG-positive, and this finding coincided with the presence of Ebola virus-specific IgG in the serum. Activated CD4 T cells ranged from 5 to 30%, compared with 1-2% in healthy controls. The most pronounced responses were seen in CD8 T cells, with over 50% of the CD8 T cells expressing markers of activation and proliferation. Taken together, these results suggest that all four patients developed robust immune responses during the acute phase of Ebola virus infection, a finding that would not have been predicted based on our current assumptions about the highly immunosuppressive nature of Ebola virus. Also, quite surprisingly, we found sustained immune activation after the virus was cleared from the plasma, observed most strikingly in the persistence of activated CD8 T cells, even 1 mo after the patients' discharge from the hospital. These results suggest continued antigen stimulation after resolution of the disease. From these convalescent time points, we identified CD4 and CD8 T-cell responses to several Ebola virus proteins, most notably the viral nucleoprotein. Knowledge of the viral proteins targeted by T cells during natural infection should be useful in designing vaccines against Ebola virus.Ebola infection | human immune response | immune activation | plasmablasts | T cells

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

“…For this analysis, we identified PfSPZ-specific T cells by the expression of IFN-γ, interleukin (IL)-2, and tumor necrosis factor (TNF)-α that was induced by ex vivo stimulation with PfSPZ antigens, and we simultaneously measured the expression of Ki-67 (a marker used to detect recent lymphocyte cell division 25 ; Fig. 5a).…”

Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study

“…Persistent immune activation, rather than direct viral cytopathic effect, has been postulated to lead to some post-EVD sequelae, although the processes are not necessarily mutually exclusive; 26 immune activation might be driven by persistent virus replication or delayed antigen clearance in immune-privileged tissues. In our study, there was no association between the level of viraemia at acute EVD presentation and convalescent arthralgias or auditory symptoms, a finding which suggests a potentially different mechanism of nonocular disease post-EVD.…”

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

“…Recently, the role of enhanced inflammation in the progression of Ebola virus disease was demonstrated (58). Four Ebola patients who received care at Emory University Hospital presented striking activation of both B and T cells that was manifested by expression of activation phenotypic markers and production of inflammatory cytokines (77). This is a significant observation that is made in humans naturally infected with Ebola virus but not in animals experimentally infected.…”